Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| MODERNA | 24 | 16 | +0,28 % | ||
| BIONTECH | 7 | 13 | +0,06 % | ||
| DISC MEDICINE | 5 | 7 | -21,74 % | ||
| VERTEX PHARMACEUTICALS | 5 | 5 | +0,59 % | ||
| ULTRAGENYX | 5 | - | +5,20 % | ||
| PTC THERAPEUTICS | 4 | 4 | +1,71 % | ||
| AMGEN | 3 | 27 | -0,02 % | ||
| 10X GENOMICS | 3 | 10 | -1,28 % | ||
| ALNYLAM PHARMACEUTICALS | 2 | 9 | +0,45 % | ||
| CRISPR THERAPEUTICS | 2 | 1 | -1,34 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit. | Suneal Sandhu | ||||
| 06:10 | uniQure: Anlegerklage nach FDA-Rückschlag - Frist für Hauptkläger endet am 13. April | 2 | Investing.com Deutsch | ||
| 04:42 | uniqure investor lawsuit deadline set for April 13 following FDA setback | 2 | Investing.com | ||
| Fr | Ocular Therapeutix, Inc.: Ocular Therapeutix to Announce Topline Data for SOL-1 Phase 3 Superiority Trial in Wet AMD on Tuesday, February 17, 2026 | 17 | GlobeNewswire (USA) | ||
| Fr | Disc Medicine plunges on FDA Complete Response Letter for bitopertin | 2 | Seeking Alpha | ||
| Fr | Orchestra BioMed Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | EQS-News: Amgen: EUROPÄISCHE KOMMISSION GENEHMIGT UPLIZNA VON AMGEN FÜR GENERALISIERTE MYASTHENIA GRAVIS | 747 | EQS Group (DE) | EQS-News: Amgen
/ Schlagwort(e): Sonstiges
EUROPÄISCHE KOMMISSION GENEHMIGT UPLIZNA VON AMGEN FÜR GENERALISIERTE MYASTHENIA GRAVIS
13.02.2026 / 22:55 CET/CEST
Für den... ► Artikel lesen | |
| Fr | Centessa Pharmaceuticals plc - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | 4D Molecular Therapeutics, Inc.: 4DMT Announces New Employment Inducement Grants | 1 | GlobeNewswire (USA) | ||
| Fr | Orchestra BioMed Holdings, Inc.: Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) | ||
| Fr | FDA lehnt Schnellzulassung für Bitopertin ab: Disc Medicine-Aktie bricht ein | 7 | Investing.com Deutsch | ||
| Fr | Expert Outlook: 10x Genomics Through The Eyes Of 10 Analysts | 1 | Benzinga.com | ||
| Fr | 10x Genomics, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| Fr | Vertex's CRISPR therapy rebounds in latest earnings | 14 | BioPharma Dive | ||
| Fr | Jefferies optimistisch: Medpace mit Turnaround-Chance | 1 | Investing.com Deutsch | ||
| Fr | Rückschlag für Disc Medicine: FDA lehnt Zulassungsantrag für Bitopertin ab | 2 | Investing.com Deutsch | ||
| Fr | FDA issues complete response letter for Disc Medicine's EPP drug | 3 | Investing.com | ||
| Fr | Disc Medicine Inc: Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP | 2 | GlobeNewswire (USA) | ||
| Fr | Ultragenyx falls as guidance trails consensus amid job cuts | 3 | Seeking Alpha | ||
| Fr | PTC Therapeutics Ends Bid to Seek FDA Approval for Rare Muscle Disease Drug | 1 | MedCity News |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.